A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is ₺8.359,77, with a 24-hour trading volume of ₺404,41M. The asset's market cap is ₺12,96T, after moving 1.21% in the last day.
Tokenized AstraZeneca PLC is trading at ₺4.170,02, with a tokenized market cap of ₺2,36B and a 24-hour trading volume of ₺28,62M. The tokenized asset has moved -10.51% in the past 24 hours.